Stock CTMX CYTOMX THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart CytomX Therapeutics, Inc.

Equities

CTMX

US23284F1057

Market Closed - Nasdaq
Other stock markets
 21:00:00 14/05/2024 BST 		5-day change 1st Jan Change
1.94 USD +2.65% Intraday chart for CytomX Therapeutics, Inc. -52.33% +25.16%
05-09 BMO Capital Adjusts Price Target on CytomX Therapeutics to $3.59 From $3.25, Maintains Market Perform Rating MT
05-09 Wedbush Upgrades CytomX Therapeutics to Outperform From Neutral, Adjusts Price Target to $8 From $3 MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
CYTOMX THERAPEUTICS, INC. Stock CytomX Therapeutics, Inc.
 131M - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 111B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 22.24B -
ARGENX SE Stock argenx SE
 21.25B -
GENMAB A/S Stock Genmab A/S
 18.97B
  1. Stock Market
  2. Equities
  3. CTMX Stock
  4. Charts CytomX Therapeutics, Inc.
  5. Sector Chart